glucosamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases visual analogue scale pain intensity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“For pain intensity, group A showed obviously lower visual analog scale scores than group B at month 6 (20.6 vs 29.2 mm; P = .007) and month 12 (17.4 vs 28.6 mm; P = .001).”
Quoted verbatim from Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial.. - Study
- RCT
- Dose
- oral glucosamine hydrochloride (1.44 g/day) for 3 months
- Population
- adults with temporomandibular joint osteoarthritis; both groups also received hyaluronate sodium intra-articular injections
Oral Glucosamine Hydrochloride Combined With Hyaluronate Sodium Intra-Articular Injection for Temporomandibular Joint Osteoarthritis: A Double-Blind Randomized Controlled Trial.2018PMID:29864430Permalink
Keep reading
- Everything the graph holds on glucosamine
- Every compound studied against Visual analogue scale pain intensity
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2RCAAQB18W57W1F3FX216RT